|
Market Closed -
Xetra
23:35:44 26/08/2026 HKT
|
After hours 01:56:22 | |||
| 22.19 EUR | -0.72% |
|
22.10 | -0.38% |
| 11:30pm | GSK's ViiV Healthcare Says US FDA Approves Tivicay PD for Pediatric HIV Patients | MT |
| 08-25 | GSK plc : Deutsche Bank remains Neutral | ZD |
Chart: Technical Analysis
Stock exchange
Xetra
GS71 22.19 €
-0.72%
282K
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
NYSE
| GSK | 51.58USD | -0.94% | 46.05M $ | |
CBOE
| GSK | 51.51USD | -1.08% | 2.51M $ | |
|
Börse Stuttgart
| GS70 | 44.20EUR | -0.90% | 8.84K € | |
|
Mexican S.E.
| GSK N | 880.00MXN | +1.85% | 9.68K $ | |
|
Deutsche Boerse AG
| GS70 | 43.60EUR | +0.46% | 0 € | |
|
Tradegate
| GS70 | 44.60EUR | 0.00% | 0 € | |
|
Boerse Muenchen
| GS70 | 44.40EUR | -0.45% | 0 € | |
London S.E.
| GSK | 1,899.50GBX | -0.31% | 5.86B p | |
|
CBOE
| GSK | 1,901.00GBX | -0.47% | 1.08B p | |
|
Xetra
| GS71 | 22.19EUR | -0.72% | 282K € | |
|
Tradegate
| GS71 | 22.09EUR | -1.16% | 145K € | |
|
Börse Stuttgart
| GS71 | 22.14EUR | -0.81% | 19.93K € | |
|
Boerse Muenchen
| GS71 | 22.23EUR | -0.67% | 14.54K € | |
|
Mexican S.E.
| GSK1 N | 426.27MXN | +19.42% | 177K $ | |
|
OTC Markets
| GLAXF | 24.60USD | -3.77% | 6.67K $ | |
|
Deutsche Boerse AG
| GS71 | 22.30EUR | +0.68% | 0 € | |
Buenos Aires S.E.
| GSK | 20,830.00ARS | +0.68% | 6.23M $ | |
|
Buenos Aires S.E.
| GSKD | 13.48USD | +1.05% | 512.24 $ | |
Sao Paulo
| G1SK34 | 53.80BRL | +3.46% | 161.4 R$ |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GSK Stock
- GS71 Stock
- Charts GSK plc
Select your edition
All financial news and data tailored to specific country editions
